Synlett 2012; 23(7): 1021-1024
DOI: 10.1055/s-0031-1290527
letter
© Georg Thieme Verlag Stuttgart · New York

Enantiospecific First Total Synthesis of ent-Allothapsenol

A. Srikrishna*
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560012, India, Fax: +91(80)3600683   eMail: askiisc@gmail.com
,
K. Mahesh
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560012, India, Fax: +91(80)3600683   eMail: askiisc@gmail.com
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 15. Januar 2012

Accepted after revision: 14. Februar 2012

Publikationsdatum:
29. März 2012 (online)


Preview

Dedicated to Professor A. J. Rao on the occasion of his 70th birthday

Abstract

The enantiospecific first total synthesis of the enantiomer of the irregular sesquiterpene from Ligusticumgrayi allo­thapsenol, starting from the readily available monoterpene (R)-carvone, is described, which confirmed the assumed absolute configuration of the natural product.

Supporting Information

 
  • References

  • 1 Cool LG, Vermillion KE, Takeoka GR, Wong RY. Phytochemistry 2010; 71: 1545
  • 4 Srikrishna A, Viswajanani R, Dinesh C. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2004; 42: 1265
  • 6 Yields refer to isolated and chromatographically pure compounds. All the compounds exhibited spectral data [IR, HRMS, 1H NMR (400 MHz) and 13C NMR (100 MHz)] consistent with their structures. Selected Spectral Data for (1R,2R,4R,6R,9S)-4-Isopropenyl-1,6,7,7-tetramethyltricyclo[4.3.0.02,9]-nonan-8-one (10): [α]D 23 +116.9 (c 3.7, CHCl3). IR (neat): νmax= 1721 (C=O), 1381, 1017, 885 cm–1. 1H NMR (400 MHz, CDCl3): δ = 4.65 (1 H, s) and 4.58 (1 H, s) [C=CH 2], 2.10–1.95 (2 H, m), 1.87 (1 H, d, J= 10.1 Hz), 1.69 (3 H, s, olefinic CH3), 1.75–1.25 (3 H, m), 1.28 (3 H, s), 1.17 (3 H, s), 1.06 (3 H, s) and 0.81 (3 H, s) [4 × t-CH3], 0.68 (1 H, td, J = 14.0, 6.4 Hz). 13C NMR (100 MHz, CDCl3): δ = 217.5 (C=O), 148.6 (C=CH2), 108.9 (C=CH2), 58.3 (C, C-7), 40.3 (C), 39.4 (CH), 38.5 (CH), 38.1 (CH2), 30.1 (CH), 28.9 (C), 26.3 (CH3), 24.7 (CH2), 24.1 (CH3), 21.3 (CH3), 19.9 (CH3), 18.6 (CH3). HRMS: m/z calcd for C16H24O [M + Na]: 255.1725; found: 255.1726.(1R,6S)-1,6,9,9-Tetramethylbicyclo[4.3.0]non-4-ene-3,8-dione (3): [α]D 23 –35.5 (c 2.4, CHCl3). IR (neat): νmax = 1737 (C=O), 1683 (C=O), 1458, 1390, 1379, 1267, 1117, 1087, 785 cm–1. 1H NMR (400 MHz, CDCl3 + CCl4): δ = 6.66 (1 H, d, J = 10.1 Hz, H-5), 5.98 (1 H, d, J = 10.1 Hz, H-4), 2.63 (1 H, d, J = 19.2 Hz), 2.47 (1 H, d, J = 16.4 Hz), 2.46 (1 H, d, J = 19.2 Hz), 2.29 (1 H, d, J = 16.4 Hz), 1.34 (3 H, s), 1.10 (3 H, s), 1.06 (3 H, s), 1.01 (3 H, s) [4 × t-CH3]. 13C NMR (100 MHz, CDCl3 + CCl4): δ = 219.9 (C, C-8), 198.8 (C, C-3), 156.8 (CH, C-5), 126.5 (CH, C-4), 53.3 (C), 48.6 (CH2), 47.8 (C), 45.0 (CH2), 41.1 (C), 25.3 (CH3), 22.8 (CH3), 22.6 (CH3), 19.5 (CH3). HRMS: m/z calcd for C13H18O2 [M + Na]: 229.1204; found: 229.1206. (1R,2R,3S,6R)-3-Hydroxy-1,2,6,9,9-pentamethylbicyclo-[4.3.0]nonan-8-one (21): [α]D 22 –54.4 (c 4.0, CHCl3). IR (neat): νmax = 3510 (OH), 1719 (C=O), 1381, 1246, 1227, 963 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.84 (1 H, br s, CHOH), 2.66 (1 H, d, J = 17.6 Hz, H-7A), 1.95 (1 H, ddd, J = 14.2, 9.3, 7.5 Hz), 1.86 (1 H, d J = 17.6 Hz, H-7B), 1.74–1.68 (2 H, m), 1.60 (1 H, br s), 1.33–1.28 (1 H, m), 1.10–1.05 (15 H, m, 4 × t-CH3 and s-CH3). 13C NMR (100 MHz, CDCl3): δ = 224.4 (C, C=O), 72.0 (CH, C-3), 54.1 (C), 48.3 (C), 47.9 (CH2), 40.1 (C), 38.1 (CH), 29.2 (CH2), 28.4 (CH2), 28.1 (CH3), 26.1 (CH3), 25.9 (CH3), 15.9 (CH3), 15.2 (CH3). HRMS: m/z calcd for C14H24O2Na [M + Na]: 247.1674; found: 247.1672.(1R,6R)-1,2,6,9,9-Pentamethyl-8-methylenebicyclo-[4.3.0]non-2-ene [Allothapsa-2,8(12)-diene (19)]: [α]D 22 –11.5 (c 1.1, CHCl3). IR (neat): νmax = 3069, 1648, 1377, 1075, 879 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.40 (1 H, br s, H-3), 4.84 (1 H, d, J= 2.2. Hz) and 4.79 (1 H, d, J = 2.3 Hz), 2.57 (1 H, dt, J = 15.6, 2.2 Hz) and 2.04 (1 H, d, J = 15.6 Hz) [H-7], 2.15–1.98 (1 H, m), 1.95–1.80 (1 H, m), 1.80–1.65 (1 H, m), 1.66 (3 H, s, vinylic CH3), 1.15–1.00 (1 H, m), 1.12 (3 H, s), 1.11 (3 H, s), 0.99 (3 H, s) and 0.90 (3 H, s) [4 × t-CH3]. 13C NMR (100 MHz, CDCl3): δ = 162.9 (C, C-8), 137.1 (C, C-2), 121.7 (CH, C-3), 104.6 (CH2, C=CH2), 51.4 (C, C-1), 47.2 (CH2), 46.7 (C), 41.2 (C), 32.3 (CH2), 31.5 (CH3), 30.3 (CH3), 22.1 (2 C, CH3 and CH2), 21.5 (CH3), 19.2 (CH3). MS: m/z (%) = 204 (100) [M+], 189 (12), 166 (22), 135 (18), 121 (100).(1R,6R,8S)-1,2,6,9,9-Pentamethylbicyclo[4.3.0]nona-2-ene-8-methanol [8-Epiallothapsenol (20)]: [α]D 22 –5.4 (c 0.4, CHCl3). IR (neat): νmax = 3338 (OH), 1545, 1377, 1083, 1067, 1018, 818, 669 cm–1. 1H NMR (400 MHz, C6D6): δ = 5.46 (1 H, br s, olefinic H), 3.51 (1 H, dd, J = 10.2, 5.8 Hz), 3.23 (1 H, dd, J= 10.2, 7.9 Hz), 2.13–1.76 (2 H, m), 1.74–1.68 (2 H, m), 1.67 (3 H, s, vinylic CH3), 1.33–1.30 (2 H, m), 1.23 (1 H, dd, J= 13.3, 9.8 Hz), 1.06 (3 H, s), 0.93 (3 H, s) 0.90 (3 H, s), 0.86 (3 H, s) [4 × t-CH3]. 13C NMR (100 MHz, C6D6): δ = 138.7 (C, C-2), 124.2 (CH, C-3), 64.9 (CH2, CH2OH), 53.6 (C), 49.2 (CH), 46.2 (C), 44.9 (CH2), 42.0 (C), 38.9 (CH2), 28.4 (CH3), 25.9 (CH3), 23.2 (CH2), 22.7 (CH3), 21.8 (CH3), 20.4 (CH3).(1R,6R,8R)-1,2,6,9,9-Pentamethylbicyclo[4.3.0]nona-2-ene-8-methanol [ent-Allothapsenol (ent-1)]: [α]D 22 –28.5 (c 0.3, CHCl3). IR (neat): νmax = 3342 (OH), 1376, 1074, 1017, 817 cm–1. 1H NMR (400 MHz, C6D6): δ = 5.42 (1 H, br s, olefinic H), 3.45 (1 H, dd, J = 10.4, 7.0 Hz), 3.26 (1 H, dd, J = 10.3, 6.7 Hz), 2.10–1.75 (4 H, m), 1.61 (3 H, s, vinylic CH3), 1.40 (1 H, br s), 1.35 (1 H, dd, J = 12.5, 5.3 Hz), 1.25 (1 H, t, J = 12.7 Hz), 1.12 (3 H, s), 0.96 (3 H, s), 0.86 (3 H, s), 0.85 (3 H, s) [4 × t-CH3]. 13C NMR (100 MHz, C6D6): δ = 137.7 (C, C-2), 122.2 (CH, C-3), 64.6 (CH2, CH2OH), 52.5 (C), 50.7 (CH), 44.2 (C), 42.8 (CH2), 42.5 (C), 33.6 (CH3), 32.9 (CH2), 23.5 (CH3), 23.3 (CH3), 22.7 (CH2), 21.7 (CH3), 20.1 (CH3)
  • 8 In addition to the acetate 11, ca. 10% of the ene-dione 3 was also obtained
  • 9 Yan T.-H, Tsai C.-C, Chen C.-T, Cho C.-C, Huang P.-C. Org. Lett. 2004; 6: 4961